Standard of Care Treatment & The EAGLE Trial Paradigm Shift
At a Glance
The standard of care for primary angle-closure glaucoma (PACG) has shifted. The EAGLE trial demonstrated that clear lens extraction often provides better eye pressure control and quality of life than traditional laser iridotomy, though the laser remains a viable option for milder cases.
For decades, the standard first-line treatment for primary angle-closure glaucoma (PACG) was a laser procedure. However, a landmark clinical trial known as the EAGLE trial has fundamentally changed how doctors approach this disease [1]. Today, you have more options—and often more effective ones—than patients had just a few years ago.
The EAGLE Trial: A New Standard of Care
The EAGLE trial (Effectiveness in Angle-closure Glaucoma of Lens Extraction) compared two treatments for patients with newly diagnosed PACG or very high eye pressure:
- Laser Peripheral Iridotomy (LPI): Using a laser to poke a tiny “safety valve” hole in the iris to help fluid circulate.
- Clear Lens Extraction (CLE): Removing the eye’s natural lens and replacing it with a thin artificial one (the same procedure as cataract surgery), even if the lens is not yet cloudy [1].
The results were a paradigm shift. The trial found that patients who chose clear lens extraction had significantly better eye pressure control and a higher reported quality of life than those who received the laser treatment [1][2]. Furthermore, while surgery has a higher upfront cost, it was found to be more cost-effective over a 10-year period because patients were far less likely to need daily eye drops or further surgeries later on [3][4].
Choosing Between Lens Extraction and Laser (LPI)
While the EAGLE trial suggests lens extraction is often superior for PACG, the choice depends on your specific eye.
- Why choose Lens Extraction? It addresses the root cause of the problem by removing the “crowding” in the eye, creating much more room for fluid to drain [2]. Many patients become “drop-free” afterward [4].
- Why choose Laser (LPI)? It is a non-surgical, office-based procedure with very low risk. While the EAGLE trial showed it is less effective than surgery for advanced PACG, LPI remains an excellent first step for patients with milder “suspect” stages (PACS), or for PACG patients who are not candidates for surgery or prefer to start with a less invasive option [5][6].
Emergency Care: Breaking an Acute Crisis
If you experience an Acute Angle-Closure Crisis (AACC)—the emergency of sudden, severe pressure—the goal is to lower the pressure as fast as possible to save the optic nerve. This is a medical emergency that usually involves a “cocktail” of medications [7]:
- Systemic Medications: High-dose pills or IV medications like acetazolamide are used to “turn off the faucet” and stop the eye from producing fluid [8].
- Topical Drops: A combination of drops like timolol (to lower fluid production) and pilocarpine (to constrict the pupil and pull the iris away from the drain) are applied frequently [9][8].
- Definitive Action: Once the pressure is lowered and the eye is stable, your doctor will likely recommend a laser iridotomy or urgent lens extraction to ensure the crisis does not happen again [10][11].
When heading to the emergency room, always bring a complete list of your current medications. If your attack was triggered by a drug (like topiramate), the medical management is different than a standard attack, and ER doctors need this context immediately.
Empowered Decision-Making
The “EAGLE paradigm” empowers you to discuss surgery earlier in your treatment journey rather than waiting until the disease becomes severe. Because every eye is different—and because surgery carries risks that lasers do not—it is essential to have a candid conversation with your specialist about which “standard of care” fits your lifestyle and your vision goals [1].
Common questions in this guide
What is the EAGLE trial for glaucoma?
Should I choose clear lens extraction or a laser procedure for PACG?
Will removing my eye's natural lens eliminate my need for eye drops?
What medications are used to treat an acute angle-closure crisis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on the EAGLE trial results, am I a candidate for early lens extraction instead of starting with laser iridotomy?
- 2.What are the specific risks of lens extraction for my eye, and how do they compare to the risk of continued pressure spikes with laser treatment?
- 3.If we choose laser iridotomy (LPI) first, what is the 'Plan B' if my eye pressure remains high or the angle stays closed?
- 4.If I experience an acute attack, exactly which emergency medications (like acetazolamide) will you use, and are there any I should avoid due to my health history?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial.
Azuara-Blanco A, Burr J, Ramsay C, et al.
Lancet (London, England) 2016; (388(10052)):1389-1397 doi:10.1016/S0140-6736(16)30956-4.
PMID: 27707497 - 2
Changing patterns in treatment of angle closure glaucoma.
Napier ML, Azuara-Blanco A
Current opinion in ophthalmology 2018; (29(2)):130-134 doi:10.1097/ICU.0000000000000453.
PMID: 29194069 - 3
Early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma: an economic evaluation based on data from the EAGLE trial.
Javanbakht M, Azuara-Blanco A, Burr JM, et al.
BMJ open 2017; (7(1)):e013254 doi:10.1136/bmjopen-2016-013254.
PMID: 28087548 - 4
Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial.
Mitchell WG, Azuara-Blanco A, Foster PJ, et al.
The British journal of ophthalmology 2023; (107(8)):1072-1078 doi:10.1136/bjophthalmol-2021-319765.
PMID: 35387778 - 5
Changes in Anterior Segment Morphology and Predictors of Angle Widening after Laser Iridotomy in South Indian Eyes.
Zebardast N, Kavitha S, Krishnamurthy P, et al.
Ophthalmology 2016; (123(12)):2519-2526 doi:10.1016/j.ophtha.2016.08.020.
PMID: 27726963 - 6
Laser Peripheral Iridotomy in Primary Angle Closure: A Report by the American Academy of Ophthalmology.
Radhakrishnan S, Chen PP, Junk AK, et al.
Ophthalmology 2018; (125(7)):1110-1120 doi:10.1016/j.ophtha.2018.01.015.
PMID: 29482864 - 7
Comparing the Safety and Efficacy of Phacogoniosynechialysis With Phacotrabeculectomy in the Management of Refractory Acute Primary Closure Angle Glaucoma With Cataract: A Multicenter Randomized Trial.
Nguyen Xuan H, Nguyen Dinh N, Nguyen Thu H, et al.
Journal of glaucoma 2021; (30(7)):552-558 doi:10.1097/IJG.0000000000001868.
PMID: 34008525 - 8
Efficacy and Safety of Argon Laser Peripheral Iridoplasty and Systemic Medical Therapy in Asian Patients with Acute Primary Angle Closure: A Meta-Analysis of Randomized Controlled Trials.
Cai W, Lou Q, Fan J, et al.
Journal of ophthalmology 2019; (2019()):7697416 doi:10.1155/2019/7697416.
PMID: 31192000 - 9
Drug-induced Acute Angle-closure Glaucoma: A Review.
Yang MC, Lin KY
Journal of current glaucoma practice 2019; (13(3)):104-109 doi:10.5005/jp-journals-10078-1261.
PMID: 32435123 - 10
Angle-closure glaucoma associated with vitreous prolapse after neodymium-doped yttrium-aluminumgarnet laser posterior capsulotomy.
Matos AG, Barbosa Neto JP, Cavalcante CPP, et al.
Arquivos brasileiros de oftalmologia 2024; (87(3)):e20220058 doi:10.5935/0004-2749.2022-0058.
PMID: 38537037 - 11
Secondary angle closure glaucoma by lupus choroidopathy as an initial presentation of systemic lupus erythematosus: a case report.
Han YS, min Yang C, Lee SH, et al.
BMC ophthalmology 2015; (15()):148 doi:10.1186/s12886-015-0144-6.
PMID: 26511325
This page provides educational information on PACG treatments and the EAGLE trial. It does not replace professional medical advice; always consult your ophthalmologist to determine the safest treatment plan for your specific eyes.
Get notified when new evidence is published on primary angle-closure glaucoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.